Clinical Trial Detail

NCT ID NCT02573259
Title A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

transitional cell carcinoma

lung non-small cell carcinoma

Therapies

PF-06801591

Age Groups: senior adult

No variant requirements are available.